First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference
October 03, 2023 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 12, 2023 16:05 ET
|
Exagen Inc.
SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor...
Zealand Pharma to participate in upcoming healthcare conferences in September 2023
September 07, 2023 11:00 ET
|
Zealand Pharma
Press release – No. 10 / 2023 Zealand Pharma to participate in upcoming healthcare conferences in September 2023 Copenhagen, Denmark, September 7, 2023 – Zealand Pharma A/S (Nasdaq: ZEAL)...
NRC Health emphasizes its commitment to ICD’s annual Patient Experience Symposium
August 31, 2023 06:55 ET
|
National Research Corporation
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- NRC Health and ICD Media Group have formalized more plans for the upcoming Patient Experience Symposium that’s taking place Sept. 18-20, 2023 in Waltham,...
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
August 29, 2023 08:30 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will...
Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress
August 14, 2023 08:05 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
NRC Health unveils winners of 2023 patient experience and loyalty awards
August 08, 2023 12:33 ET
|
National Research Corporation
LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health, a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty...
NRC Health unveils winners of 2023 patient experience and loyalty awards
August 08, 2023 08:55 ET
|
National Research Corporation
LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health, a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty...
Recursion to Participate in Upcoming Investor Conference
August 01, 2023 08:30 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Myriad Genetics to Participate in Goldman Sachs Healthcare Conference
June 07, 2023 16:05 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, president and CEO, will...